Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALSUntangled does not support luteolin supplements for ALS

Original source

Luteolin and LutimaxALSUntangled · 5 May 2011 (opens in a new tab)

ALSUntangled said convincing evidence that luteolin helps people with amyotrophic lateral sclerosis (ALS) is not available. It also raised safety concerns, including possible unwanted weight loss linked to a carbohydrate-deficient diet and an anecdotal report of faster disease progression. The group advised against luteolin-containing products until controlled human safety and efficacy studies are completed.

Why this matters

This applies to people with ALS considering luteolin or products such as Lutimax. The review does not establish a treatment benefit, and its recommendation means luteolin should not be viewed as a proven ALS therapy.

Limitations and context

This is an expert review published in 2011, not a new clinical trial. The source says the evidence comes from various models and that convincing human ALS data were lacking; one progression concern was anecdotal. Controlled human studies would still be needed to assess safety and effectiveness.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?